Mallinckrodt plc Stock News

Golden State Wealth Management LLC acquired a new position in shares of Mallinckrodt PLC (NYSE:MNK) during the first quarter, according to the company in its most recent filing with the Securities & E

Mallinckrodt (NYSE:MNK) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Monday, ValuEngine reports. Other equities research an

Mallinckrodt PLC (NYSE:MNK)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $3.33, but opened at $3.57. Mallinckrodt shares last traded at $3.53, with a v

Ladenburg Thalmann Financial Services Inc. lowered its holdings in Mallinckrodt PLC (NYSE:MNK) by 13.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 56,800 shares of the company

One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky...

A small-cap pharmaceuticals company may hold the solution to a nearly 100,000% drug price hike.

This article presents a list of stocks with the highest short interest as a percentage of shares outstanding. Short-sellers are having a banner year with broad-

LONDON, UK / ACCESSWIRE / April 17, 2020 / The year 2019 marked a major turnaround for Silence (LSE:SLN), as it both ramped up its development activity, with the advancement of SLN124 for iron overloa

ROCKVILLE, MD / ACCESSWIRE / April 16, 2020 / In its third week of providing emergency grants to low-income dialysis and post-transplant patients struggling to afford renal-friendly food, transportati

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will report first quarter 2020 earnings results for the period ended March 27, 2020 on Tuesday, May 5, 2020.

The FDA has signed off on Fast Track status for Yantai, China-based RemeGen's lead drug RC18 for the treatment of systemic lupus erythematosus (SLE).RC18 (telitacicept) is a recombinant TACI-F

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs April 14) * Bio-Rad Laboratories, Inc. (NYSE: BIO) * Accelero

Mallinckrodt (NYSE:MNK) announces positive results from a Phase 4 clinical trial evaluating Acthar Gel (repository corticotropin injection) in patients with persistently active rheumatoid arthritis &